No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CMRX Chimerix
- 2.990
- +0.140+4.91%
Close Dec 20 16:00 ET
- 3.039
- +0.049+1.62%
Post 20:01 ET
268.91MMarket Cap-3.18P/E (TTM)
3.200High2.801Low2.53MVolume2.850Open2.850Pre Close7.67MTurnover3.37%Turnover RatioLossP/E (Static)89.94MShares3.39052wk High1.98P/B224.42MFloat Cap0.75052wk Low--Dividend TTM75.06MShs Float58.040Historical High--Div YieldTTM14.02%Amplitude0.750Historical Low3.036Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Is Chimerix (NASDAQ:CMRX) In A Good Position To Invest In Growth?
H.C. Wainwright Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $11
HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target
Chimerix Analyst Ratings
Edward White's Buy Rating on Chimerix Driven by Promising Clinical Data and Strategic NDA Plans
CervoMed CRVO Phase 2b Fails; Chimerix SNDA Application
Heat List
US
Overall
Symbol
Price
% Chg
No Data
